Literature DB >> 33501548

The right stuff? Imaging cardiac sympathetic neuronal integrity of the right ventricle in pulmonary arterial hypertension.

James T Thackeray1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33501548     DOI： 10.1007/s12350-020-02495-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  17 in total

1.  Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.

Authors:  Harm J Bogaard; Ramesh Natarajan; Shiro Mizuno; Antonio Abbate; Philip J Chang; Vinh Q Chau; Nicholas N Hoke; Donatas Kraskauskas; Michael Kasper; Fadi N Salloum; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

2.  Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension.

Authors:  Agnieszka Ciarka; Vi Doan; Sonia Velez-Roa; Robert Naeije; Philippe van de Borne
Journal:  Am J Respir Crit Care Med       Date:  2010-03-01       Impact factor: 21.405

3.  Multiparametric molecular imaging provides mechanistic insights into sympathetic innervation impairment in the viable infarct border zone.

Authors:  Riikka Lautamaki; Tetsuo Sasano; Takahiro Higuchi; Stephan G Nekolla; Albert C Lardo; Daniel P Holt; Robert F Dannals; M Roselle Abraham; Frank M Bengel
Journal:  J Nucl Med       Date:  2015-01-29       Impact factor: 10.057

4.  Regional pre- and postsynaptic sympathetic system in the failing human heart--regulation of beta ARK-1.

Authors:  M Ungerer; H J Weig; S Kübert; M Overbeck; F Bengel; A Schömig; M Schwaiger
Journal:  Eur J Heart Fail       Date:  2000-03       Impact factor: 15.534

5.  Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.

Authors:  Arnold F Jacobson; Roxy Senior; Manuel D Cerqueira; Nathan D Wong; Gregory S Thomas; Victor A Lopez; Denis Agostini; Fred Weiland; Harish Chandna; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2010-02-25       Impact factor: 24.094

6.  The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up.

Authors:  Sally H Vitali; Georg Hansmann; Chase Rose; Angeles Fernandez-Gonzalez; Annette Scheid; S Alex Mitsialis; Stella Kourembanas
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

7.  Test-retest repeatability of quantitative cardiac 11C-meta-hydroxyephedrine measurements in rats by small animal positron emission tomography.

Authors:  James T Thackeray; Jennifer M Renaud; Myra Kordos; Ran Klein; Robert A Dekemp; Rob S B Beanlands; Jean N DaSilva
Journal:  Nucl Med Biol       Date:  2013-05-08       Impact factor: 2.408

Review 8.  Assessment of cardiac autonomic neuronal function using PET imaging.

Authors:  James T Thackeray; Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2013-02       Impact factor: 5.952

9.  Quantification of [(11)C]-meta-hydroxyephedrine uptake in human myocardium.

Authors:  Hendrik J Harms; Stefan de Haan; Paul Knaapen; Cornelis P Allaart; Mischa T Rijnierse; Robert C Schuit; Albert D Windhorst; Adriaan A Lammertsma; Marc C Huisman; Mark Lubberink
Journal:  EJNMMI Res       Date:  2014-09-26       Impact factor: 3.138

10.  Bisoprolol therapy does not reduce right ventricular sympathetic activity in pulmonary arterial hypertension patients.

Authors:  Mischa T Rijnierse; Joanne A Groeneveldt; Jasmijn S J A van Campen; Karin de Boer; Cathelijne E E van der Bruggen; Hendrik J Harms; Pieter G Raijmakers; Adriaan A Lammertsma; Paul Knaapen; Harm Jan Bogaard; Berend E Westerhof; Anton Vonk Noordegraaf; Cornelis P Allaart; Frances S de Man
Journal:  Pulm Circ       Date:  2020-04-20       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.